Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors of in total USD 85 million in Voi Technology AB, a company that provides an electric scooter sharing service.
Vostok is an investment and asset management company that invests in both private equity and public equity markets with a special focus on online marketplaces and businesses with strong network effects. The Swedish depository receipts of Vostok are listed on Nasdaq Stockholm, Mid Cap segment.
Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
